The largest database of trusted experimental protocols

4 protocols using anti transferrin receptor

1

Immunolocalization of GlyT2 in Rat Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female Wistar rats were bred under standard conditions at the Centro de Biología Molecular Severo Ochoa (CBMSO) in accordance with procedures approved in the Directive 2010/63/EU of the European Union with approval of the Research Ethics Committee of the Universidad Autónoma de Madrid (Comité de Ética de la Investigación UAM, CEI-UAM). Rabbit and rat antibodies against N-terminus of GlyT2 were generated in house (Zafra et al., 1995) . Other primary antibodies used were: anti-transferrin receptor (Invitrogen, #13-6800), anti-E cadherin (a gift from Amparo Cano, UAM), rabbit anti-calnexin (StressMarq Biosciences, SPC-108), mouse anti-calnexin (BD Transduction Laboratories, clone 37), anti-ubiquitin (Santa Cruz, sc-8017, clone P4D1), anti-α-tubulin (Sigma-Aldrich, clone T-6074), anti-Myc (Cell Signaling, #2276) and anti-transferrin receptor (Invitrogen). For the screening of compounds with the potential to rescue GlyT2 defective phenotypes the following chemicals were used: bupropion Neurobasal medium and B27 supplement were purchased from Invitrogen.
+ Open protocol
+ Expand
2

GlyT2 Defective Phenotypes Rescue Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female Wistar rats were bred under standard conditions at the Centro de Biología Molecular Severo Ochoa (CBMSO) in accordance with procedures approved in the Directive 2010/63/EU of the European Union with approval of the Research Ethics Committee of the Universidad Autónoma de Madrid (Comité de Ética de la Investigación UAM, CEI-UAM). Rabbit and rat antibodies against N-terminus of GlyT2 were generated in house (Zafra et al. 1995) . Other primary antibodies used were: anti-transferrin receptor (Invitrogen, #13-6800), anti-E cadherin (a gift from Amparo Cano, UAM), rabbit anti-calnexin (StressMarq Biosciences, SPC-108), mouse anti-calnexin (BD Transduction Laboratories, clone 37), anti-ubiquitin (Santa Cruz, sc-8017, clone P4D1), anti-α-tubulin (Sigma-Aldrich, clone T-6074), anti-Myc (Cell Signaling, #2276) and anti-transferrin receptor (Invitrogen). For the screening of compounds with the potential to rescue GlyT2 defective phenotypes the following chemicals were used: bupropion hydrochloride (Sigma Aldrich), ibogaine hydrochloride (LGC Standards), ALX1393 (Santa Cruz Biotechnology), N-arachidonoyl glycine (Cayman chemicals) and 4-phenylbutirate (Sigma Aldrich). All other chemicals used were from Sigma Aldrich unless otherwise noticed. Neurobasal medium and B27 supplement were purchased from Invitrogen.
+ Open protocol
+ Expand
3

Cell Labeling and Ligand Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Myrcludex B and Myrcludex B labeled with fluorescein isothiocyanate (FITC) were custom synthesized by Pepscan (Lelystad, The Netherlands), with the FITC modification located at the side-chain of the C-term lysine. Hoechst 33342 was obtained from Merck Millipore (Darmstadt, Germany). [3H]Taurocholic acid (1mCi/ml) were purchased from PerkinElmer (Groningen, The Netherlands). Acyl carrier protein (ACP) synthase (P9301) and CoA-DY547 (S9249S) were obtained from New England Biolabs (Ipswich, USA). The following antibodies and beads were used: anti-hemagglutinin (HA) agarose beads (Sigma Aldrich, A2095), anti-HA horse radish peroxidase (HRP) (Sigma Aldrich, H6533), anti-FLAG® (Sigma Aldrich, F1804), anti-transferrin receptor (Invitrogen, 13-6890), anti-mouse-HRP (DAKO, P0447), also shown in the supplementary CTAT table.
+ Open protocol
+ Expand
4

Subcellular Fractionation and GPER Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
JKT-1 cells were grown in 10-cm dishes at a density of 4.9 × 106 cells per dish. After 48 h, the JKT-1 cells were scraped in 5 mL cold PBS, pelleted and homogenized in 250 μL cold SI buffer (250 mM sucrose, 3 mM imidazole, pH 7.4, 1 mM PMSF protease inhibitor). Cells were lysed by passing 40 times through a 25G needle (U-100 Insulin, Terumo®, Somerset, NJ, USA). Nuclei were removed by centrifugation for 10 min at 10,000 g at 4 °C. Protein concentration of the post-nuclear supernatants (PNS) was normalized. PNS were centrifuged for 1 h at 100,000 g at 4 °C. Supernatants correspond to the cytosolic fraction. Pellets, homogenized in an equal volume of SI buffer, correspond to membranes.
Equal amounts (30 μL) of each fraction were resolved on a 12% SDS-polyacrylamide gel. The proteins were transferred to a polyvinylidene difluoride membrane (Immobilon P; Millipore™, Billerica, MA, USA), probed with anti-GPER Ab (Santa Cruz Biotechnology®, Santa Cruz, CA, USA) and with anti-Rho-GDIα (Santa Cruz Biotechnology®, Santa Cruz, CA, USA) and anti-transferrin receptor (Invitrogen®) Abs to control fractionation, then detected using HRP-linked secondary Ab and the ECL System (GE Healthcare®, Chalfont St. Giles, UK). All experiments were performed in triplicate and the blots shown are representative.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!